![](/img/cover-not-exists.png)
Pulmonary nodules and immunotherapy: disease progression or toxicity of anti-PD1/anti-PDL1 checkpoint inhibitors?
Pradère, P., Boutros, C., Scoazec, J.Y., Dorfmüller, P., Leroy-Ladurie, F., Boulate, D., Le Pavec, J., Robert, C.Language:
english
Journal:
European Journal of Cancer
DOI:
10.1016/j.ejca.2017.12.013
Date:
February, 2018
File:
PDF, 596 KB
english, 2018